StockData
Intuitive Surgical Inc logo

Intuitive Surgical Inc (ISRG) operating KPIs

ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 17/3023% above fair value
$432.01−16.75 (-3.73%)

Close on Oct 30, 2026Market cap $152.62BP/E 49.5Yield –

Intuitive Surgical intuitive Surgical — FDA MAUDE Patient Injury Reports

U.S. FDA openFDA API (/device/event)

QuarterlyAnnualMonthly
Latest, Q3 2026
812
Period ended Sep 30, 2026
Change on a year earlier
+36.0%
597 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR)

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIntuitive Surgical — FDA MAUDE Patient Injury ReportsYear on yearSource
Q3 2026Sep 30, 2026812+36.0%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2026Jun 30, 2026793+20.5%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2026Mar 31, 2026677+27.3%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2025Dec 31, 2025678-7.0%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q3 2025Sep 30, 2025597-2.0%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2025Jun 30, 2025658+12.7%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2025Mar 31, 2025532+1.7%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2024Dec 31, 2024729+32.1%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q3 2024Sep 30, 2024609+29.6%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2024Jun 30, 2024584-31.6%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2024Mar 31, 2024523+9.6%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2023Dec 31, 2023552+22.9%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q3 2023Sep 30, 2023470+6.6%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2023Jun 30, 2023854+18.4%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2023Mar 31, 2023477+89.3%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2022Dec 31, 2022449+85.5%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗

Cite this data

StockData. (2026). Intuitive Surgical Intuitive Surgical — FDA MAUDE Patient Injury Reports, quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Intuitive Surgical SEC filings and investor materials. https://stockdatahq.com/stocks/isrg/kpis/ext-fda-maude-co-inj

See every metric in the Intuitive Surgical KPI table. Data updated Oct 28, 2026.